Avoiding Premature Antibiotic Use in Recurrent Clostridioides difficile Infection After Fecal Microbiota Transplant

Recurrent <i>Clostridioides difficile</i> infection (rCDI) remains a major clinical challenge, often requiring fecal microbiota transplantation (FMT) after conventional treatment fails. An 86-year-old woman with rCDI underwent FMT after failing multiple antibiotic therapies. Shortly after FMT, she experienced diarrhea and abdominal pain, alongside positive <i>C. difficile</i> stool tests. Antibiotics were withheld because of clinical improvement, and she achieved complete resolution of symptoms without further treatment. This case demonstrates the potential benefit of withholding antibiotics in rCDI patients soon after FMT to allow sufficient time for donor microbiota engraftment and underscores the need for further research to optimize post-FMT management.

Authors

Institutions

Publication Details

Journal
ACG Case Reports Journal
Published
2025-04-01
DOI
https://doi.org/10.14309/crj.0000000000001660
Citations
1
Primary Topic
Clostridium difficile and Clostridium perfringens research
Type
article
Field-Weighted Citation Impact
1.40
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Avoiding Premature Antibiotic Use in Recurrent Clostridioides difficile Infection After Fecal Microbiota Transplant

Brian W. Behm, Cirle Alcantara Warren, Caroline C. Whitt, Rahim A. Burdette
1 citations
ACG Case Reports Journal
Clostridium difficile and Clostridium perfringens research
1.40
article

Avoiding Premature Antibiotic Use in Recurrent Clostridioides difficile Infection After Fecal Microbiota Transplant

Brian W. Behm, Cirle Alcantara Warren, Caroline C. Whitt, Rahim A. Burdette
article en
1 citations

Abstract

Recurrent <i>Clostridioides difficile</i> infection (rCDI) remains a major clinical challenge, often requiring fecal microbiota transplantation (FMT) after conventional treatment fails. An 86-year-old woman with rCDI underwent FMT after failing multiple antibiotic therapies. Shortly after FMT, she experienced diarrhea and abdominal pain, alongside positive <i>C. difficile</i> stool tests. Antibiotics were withheld because of clinical improvement, and she achieved complete resolution of symptoms without further treatment. This case demonstrates the potential benefit of withholding antibiotics in rCDI patients soon after FMT to allow sufficient time for donor microbiota engraftment and underscores the need for further research to optimize post-FMT management.

ACG Case Reports JournalVol. 12(4)
University of Virginia (US)
Good health and well-being
Openalex Percentile: Top 22%
Clostridium difficile and Clostridium perfringens research
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Avoiding Premature Antibiotic Use in Recurrent Clostridioides difficile Infection After Fecal Microbiota Transplant — Brian W. Behm, Cirle Alcantara Warren, et al. · ACG Case Reports Journal (2025) | TGRS Research Map | TGRS